Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
Professor Maggioni said: “Recommendations in guidelines are referred to as ‘optimal therapy’ but the ESC-HF Pilot showed that many HF patients do not receive recommended drugs and doses.1 Previous studies have not reported the reasons why recommendations are sometimes not followed in clinical practice.”
Professor Maggioni said: “When reasons for non-adherence are taken into account, drug treatment of patients with chronic HF complies acceptably with guidelines. Our results suggest that the dosages used in clinical practice may meet patient need and tolerance to drugs.”
He concluded: “Our registry reveals patchy adherence to guidelines in acute HF, acceptable use of drug treatments in chronic HF but sub-optimal use of devices. The practicalities of adhering to guidelines in daily clinical practice should be taken into account when guidelines are being written, particularly since failure to comply may have legal consequences in some countries.”
Our mission: To reduce the burden of cardiovascular disease.
© 2020 European Society of Cardiology. All rights reserved.